FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.
News for GlaxoSmithKline Consumer Healthcare Ltd. HUL Faces Rs 963 Cr Income Tax Demand: Appeal Planned Hindustan Unilever (HUL) received a Rs 963 crore Income Tax demand for non-deduction of TDS on ...
Bonus Sep 11, 2018 Sep 13, 2018 Jul 24, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jan 02, 1995 Jan 24, 1995 Sep 28, 1995 Bonus Ratio: 1 share(s) for every 1 shares held Rights May 21, ...